首页> 中文期刊> 《中国生化药物杂志》 >普米克令舒雾化吸入治疗小儿急性感染性喉炎的疗效观察

普米克令舒雾化吸入治疗小儿急性感染性喉炎的疗效观察

         

摘要

Objective To explore the clinical effects of atomization inhalation pulmicort respules in treatment with pediatric acute infectious laryngitis. Methods 104 cases with pediatric acute infectious laryngitis admitted in Xiaoshan Hospital of Zhejiang Province from January 2011 to July 2013 were radomly divided into experimental group(n=52)and control group(n=52). Patients in experimental group were given atomization inhalation pulmicort respules,and patients in control group were received dexamethasone by intravenous injection. The symptom improvement,disappearing times of symptoms and therapeutic effect in two groups were observed and compared. Results Compared with control group,the improvement scores were higher,and disappearing time of symptoms were shorter in experiment group(P<0.05). The therapeutic effect in experimental group was up to 100%, while control group was 90.74%,and the difference between them was statistically significant(P<0.05). Conclusion Compared with dexamethasone, atomization inhalation pulmicort respules has advantages in treatment with pediatric acute infectious laryngitis,with better efficacy,shorter treatment time and fewer side effects.%目的:探讨采用雾化吸入普米克令舒药物对小儿急性感染性喉炎患儿的治疗疗效。方法选取2011年1月~2013年7月浙江萧山医院收治的的小儿急性感染性喉炎患儿104例,随机分成实验组(n=52)和对照组(n=52)。实验组采用雾化吸入普米克令舒的方式治疗,对照组采用静脉注射地塞米松的方式治疗。观察并记录2组患儿的病情改善情况、病症消失时间与治疗有效率。结果治疗后实验组患儿各项症状改善总体得分高于对照组,各症状消失时间也短于对照组,治疗有效率为100%,高于对照组的90.74%,2组差异均具有统计学意义(P<0.05)。结论相比静脉注射地塞米松,在治疗小儿急性感染性喉炎方面雾化吸入普米克令舒具有更好的治疗效果,更短的治疗时间以及更少的不良反应。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号